16 th Working Groups Meeting of the Scandinavian Sarcoma Group Copenhagen

Similar documents
FINAL PROGRAM. The 36 th Meeting of the Scandinavian Sarcoma Group

The 33 rd Meeting of the Scandinavian Sarcoma Group

The 34 th Meeting of the Scandinavian Sarcoma Group 30 Years Jubilee

EFORT Spring Travelling Fellowship

ADJUVANT TREATMENT CLINICAL EVALUATION NEOADJUVANT TREATMENT

Complement in human disease, September 8th - 12th 2017

The importance of international. Collaborations in rare diseases

Soft tissue sarcoma. 329 Soft tissue sarcoma Page 1 of 11

MUSCULOSKELETAL ONCOLOGY COURSE

Worsening thigh pain after blunt trauma

EFORT Spring Travelling Fellowship

Gentofte Workshop. Gentofte University Hospital Copenhagen, Denmark. Basic course in CT guided lung biopsy 19th and 20th November 2012

ONDON. Complications in Spine Surgery An International Educational Training Program. Course Chairmen: 5-6 June, 2015 London, UK

Gentofte Workshop 2013

Primary Extradural Tumours and Metastasis of the Spine. Cody Bünger Spine Center/Sarcoma Center Aarhus University Hospital, Aarhus Sygehus Denmark

Recommendations for cross-sectional imaging in cancer management, Second edition

Clinical Commissioning Policy: Proton Beam Radiotherapy (High Energy) for Paediatric Cancer Treatment

Navigating GIST. The Life Raft Group June 12, 2008

Final Announcement. The Danish and Swedish Societies of Shoulder and Elbow Surgery In cooperation with Danderyd Hospital invite you to the

Gentofte Workshop. Gentofte. Hospital 10/2012. University. Training Centre

Rotation Specific Goals & Objectives: University Health Network-Princess Margaret Hospital/ Sunnybrook Breast/Melanoma

Additional activities will be arranged in order to increase your profile with respect to both existing and potential partners in Brazil.

1 page Overview. CONCURRENT 1D, 1E, 1F Biology & Pathogenesis Multi-Modality Immunology 1

INTERDISCIPLINARY CONFERENCE. Florence/Firenze, Italy Nov 27-29, 2012 Centro Congressi al Duomo, Firenze BREAST SEMINAR SERIES

BJJ / EFORT Travelling Fellowship

SPONSOR AND EXHIBITOR INFORMATION

Guideline for the Imaging of Patients Presenting with Breast Symptoms incorporating the guideline for the use of MRI in breast cancer

Clinical Management Guideline Management of locally advanced or recurrent Renal cell carcinoma. Protocol for Planning and Treatment

2015 CAPHC Annual Conference

Acute Oncology Service Patient Information Leaflet

How To Prepare A Meeting For A Health Care Conference

Breast Health Program

18 th Plenary Meeting of the European Lifelong Guidance Policy Network September 2015, Luxemburg

XXVIIII Annual Meeting Danish Society for Neuroscience (DSfN) Stem Cells in a Neurotranslational Perspective. May 11 12; 2015

Cancer doesn t care but we do Cancer Annual Report

Cancerfondens planeringsgrupp för Onkologisk Nuklidterapi meeting November 2015

BOD/2016/06 DOC 01 Board of Directors Meeting and Retreat June 13 15, 2016 Scandic Holmenkollen Park Hotel, Oslo, Norway

19-23 May 2014, Helsinki, Finland EXHIBITION GUIDE

Welcome to. May 28-30, 2006

Cancer Care Delivered Locally by Physicians You Know and Trust

METASTASES TO THE BONE

Komorbide brystkræftpatienter kan de tåle behandling? Et registerstudie baseret på Danish Breast Cancer Cooperative Group

Final Programme. The Road to Green Growth and Sustainable Development. Chairpersons Meeting for Environment and Foreign Affairs Committees

Breast. Patient information. cancer clinical pathway

#ppd2015 P D WORKSHOP PUBLIC-PRIVATE DIALOGUE MARCH 10-13, 2015 COPENHAGEN

Mesothelioma. 1. Introduction. 1.1 General Information and Aetiology

ductal carcinoma in situ (DCIS)

Understanding ductal carcinoma in situ (DCIS) and deciding about treatment

WONDERFUL COPENHAGEN TAEKWONDO TOURNAMENT TOURNAMENT

Scientific Program Nordiatrans 41st Congress Oslo 8 9 March 2013 Theme: Early versus late

«If the patient could decide» - diagnosis and treatment of breast cancer

2nd International Symposium on Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC)

Surgical guidelines for the management of breast cancer

Breast Cancer Care & Research

Departments of Nuclear Medicine, Surgery, and Endocrinology University of Ulm

GUIDELINES FOR ASSESSMENT OF SPINAL STABILITY THE CHRISTIE, GREATER MANCHESTER & CHESHIRE. CP57 Version: V3

The Cancer Patient Journey. Dr. Jaco Fourie

Targeted Therapy What the Surgeon Needs to Know

SCANDINAVIAN CONFERENCE

How To Manage A Cancer Oncology Clinic

The Role of the MDT Coordinator. Laura Throssell

Advances in Lung Cancer: A Multidisciplinary Approach

A practical guide to understanding cancer

1400 Telegraph Bloomfield Hills, MI Phone number/ fax Number CANCER TREATMENT

Lung Cancer in 2015: A Multidisciplinary Update

PRODYNOV. Targeted Photodynamic Therapy of Ovarian Peritoneal Carcinomatosis ONCO-THAI. Image Assisted Laser Therapy for Oncology

RT for Recurrent, Bulky, and Chemotherapy-Refractory Follicular Lymphoma: A Treatment Modality for Both Alleviating Symptoms and Potential Cure

Oncology Nurse Care Coordinators as. Navigators. Improving cancer disease management and the patient experience

It s all about Europe s future with Cloud. EUROCLOUD FORUM th EuroCloud Congress Barcelona, October 7 9

Annex A REGISTRATION FORM. 12 th Eastern Atlantic Hydrographic Commission Conference Lisbon, Portugal 14 th November to 16 th November 2012

Report series: General cancer information

CASE OF THE MONTH AUGUST-2015 DR. GURUDUTT GUPTA HEAD HISTOPATHOLOGY

In Practice Whole Body MR for Visualizing Metastatic Prostate Cancer

An Integrated Approach to Lung Cancer in a Community Setting

Goals and Objectives: Breast Cancer Service Department of Radiation Oncology

Welcome to Trondheim by Dean Espen Gressetvold, Trondheim Business School (TBS)

The Center for Prostate Cancer. Personalized Treatment. Clinical Excellence.

Orthopedic. Nursing Symposium HOAG ORTHOPEDIC INSTITUTE AND THE ORANGE COUNTY CHAPTER OF NAON PRESENTS: 7 TH ANNUAL MONDAY, OCTOBER 26, AM 4 PM

Abdominal Ultrasound

ANNOUNCEMENT ISU SYNCHRONIZED SKATING JUNIOR WORLD CHALLENGE CUP TH -13 TH MARCH 2010 GÖTEBORG, SWEDEN

Treatment of colon cancer

MesoPDT. Photodynamic Therapy for malignant pleural mesothelioma ONCO-THAI. Image Assisted Laser Therapy for Oncology

Using Agile IT to Improve Multi- Disciplinary Team Coordination

CANCERS OF THE PERITONEUM PERITONEAL MESOTHELIOMA PREFERRED MODEL OF CARE AND CRITERIA FOR REFERENCE CENTRES

Final announcement Joint meeting in Radiation Biology and Radioecology

AO Course 7th Nordic Advanced Trauma Course. Preliminary Program 3rd 7th May, Bergen, Norway

CARDIOVASCULAR PROBLEMS IN SURVIVORS OF CHILDHOOD CANCER AND THEIR SIBLINGS

Breast cancer research and a changing treatment pathway

Clinic Name and Location: 4. Clinic has specific written protocols or guidelines for treatment of TB:

Fundamentals of Spine Surgery and Interventional Pain Management

WELCOME TO MALMÖ! ARRIVAL AT COPENHAGEN AIRPORT REGISTRATION ACCREDITION

Objectives. Mylene T. Truong, MD. Malignant Pleural Mesothelioma Background

Coversheet for Network Site Specific Group Agreed Documentation

How To Contact The Lung Cancer And Mesothelioma Multi-Disciplinary Team

Mifamurtide (Mepact ) for Osteosarcoma

Management of spinal cord compression

Danish Swimming Association is inviting you to Open Danish East Masters Championship th January 2010

ACUTE STROKE PATHWAY

Transcription:

16 th Working Groups Meeting of the Scandinavian Sarcoma Group Copenhagen Final Program Date: November 28 30, 2010 DGI-byens Hotel, DGI-byen, Tietgensgade 65, DK-1704 Copenhagen V Tel: +45 33 29 80 50 Fax: +45 33 29 80 59 hotel@dgi-byen.dk www.dgi-byen.dk

Introduction Welcome to the 16 th Scandinavian Sarcoma Group Working Committee Meeting in Copenhagen 2010. As always, the agenda for the meeting is comprehensive. Below please find a summary of the issues which will be discussed (in accordance to expected progression). 1. We will receive a report by the Chairman of the register, C. Trovik, on the plans for increasing the quality of the SSG central register. To underline the importance of the Central register, the working group will during the meeting come together to thoroughly discuss various problems related to the registration. 2. With SSG currently participating in two global registration studies, M. Eriksson will present the recent developments of this work. 3. With Euramos expected to reach the intended number of patients (n=2000) in early 2011, upon which it will close, S. Smeland will present the progression on the work on establishing a new international protocol. Notably, important decisions must be made by SSG on how to proceed and delegate working tasks regarding the upcoming new protocol. 4. M. Skorpil will present proposals for imaging modalities in the next bone sarcoma protocol. 5. The status of the planned thesis of N. Jebsen (Effects of surgery and radiotherapy in soft tissue sarcoma of extremities and trunk wall), and status of our SSG XX protocol (K. Sundby Hall) will be presented. 6. All working committees will discuss selected topics and also patients who are entering the different SSG protocols to enhance the reporting and quality of trial data. 7. Unfortunately, gaining financial support for the SSG`s activities has proved more difficult in recent years. Therefore, it has become necessary to charge a modest registration fee for attendance this year. All chairmen of the working committees should send their report from the meeting to the SSG`s Secretariat (ssg@med.lu.se) before December 15 th, 2010. The preliminary dates for the next Working Committee Meeting are Nov 27- Nov 29 th, 2011. DGI-byens Hotel. The 35 rd SSG plenary meeting 2011 will be held in Malmø May 4-6 th with many interesting topics on the agenda. Several foreign speakers are invited. Please refer to www.ssg-org.net for program details. Notably, our Scandinavian multidisciplinary cooperation is central in maintaining a high quality of diagnosis, treatment and follow-up of patients with bone- and soft tissue sarcoma. We should therefore strengthen such cooperation in the future. Kirsten Sundby Hall Otte Brosjø Chairmen, Scandinavian Sarcoma Group 2

Sunday November 28, 2010 17.00 19.30 Board meeting, Meeting room 5 20.00 Dinner, board members, Rio Bravo Restaurant -------------------- Arrival Monday November 29, 2010 07.00 08.30 Breakfast, Registration 08.30 12.00 Joint meeting, Meeting room: Plenum Chairmen: K. Sundby Hall, Oslo, O. Brosjö, Stockholm 08.30 SSG central register: status and future plans 9.00 SSG`s participation in various global registration studies. Status M. Eriksson, Lund, S. Smeland, Oslo 09.15 Osteosarcoma protocols: status and future plans for SSG S. Smeland, Oslo 09.45 Imaging modalities in the next bone sarcoma protocols: proposals by the radiologist M. Skorpil, Stockholm 10.10 Coffee 10.40 Status of Effect of surgery and radiotherapy in soft tissue sarcoma of extremities and trunk wall a thesis project N. Jebsen, Bergen 11.00 Status of SSG XX protocol K. Sundby Hall, Oslo 11. 15 SSG matters K. Sundby Hall, Oslo, O. Brosjø, Stockholm 12.00 13.00 Lunch, Vesrestaurangen 13.00 19.00 SSG working group meetings 20.00 Dinner, Vesrestaurangen 3

Tuesday November 30, 2010 07.30 08.30 Breakfast 08.00 09.30 SSG central register meeting, Meeting room: Meet in art Chairmen: 08.30 11.00 Cont. SSG working group meetings 10.30 Coffee 11.00 13.00 Joint meeting, Meeting room: Plenum Chairmen: K. Sundby Hall, Oslo, O. Brosjø, Stockholm Reports from all groups SSG central register 13.00 14.00 Lunch SSG Morphology, Tumor biology group B. Bjerkehagen, Oslo SSG Orthopedic surgery group SSG Imaging group M. Skorpil, Stockholm SSG Oncology group S. Smeland, K. Sundby Hall, Oslo, L. Hjorth, Lund SSG Nurse and Physiotherapists group C. Våde, Oslo 14.00 17.00 SSG Visceral and retroperitoneal sarcoma working group Meeting room: Plenum 4

Central register working group Date: November 30, 2010, 08.00 09.30 Chairman: Meeting room: Meet in Art Update on register status Discussions: - Criteria for quality checks - Which patients should be followed, and for how long? The following criteria s has been suggested: - FU every 15 months Remove following patients with: - >5 years after diagnose or recurrence all patients can not be followed more than 5 years - desmoids/aggressive fibromatosis - giant cell tumors - liposarcoma grade I. 5

Morphology /tumor biology working group Date: November 29, 2010, 13.00 19.00 November 30, 2010, 08.30 11.00 Chairman: Meeting room: Istedgade B. Bjerkehagen, Oslo Bruk av diagnostiske maler, skal SSG samordne dette? Krav til genetisk informasjon ved diagnostikk for eksempel ved Ewings sarkom og GIST. - GIST - bløtvevssarkom - bensarkom Tema for reviewwmøtene fremover utover revidering av kasus inkludert i behandlingsprotokoller Validering av databasen på bakgrunn av reviderte preparater Eventuelt 6

Orthopedic working group Date: November 29, 2010, 13.00 19.00 November 30, 2010, 08.30 11.00 Chairman: Meeting room: Enghave plads/ködbyen Evaluation of photochemical internalization for treatment of sarcomas a possible new treatment of modality? O.J. Norum, Radiumhospitalet, Oslo Radiotherapy or Surgery for Ewing sarcoma of the axial skeleton? Discussion. Disappearing Spine. A Diagnostic and Therapeutic Challenge. G. Gunterberg, Sahlgrenska Hospital, Gothenburg All participants will be present illustrated cases, for detailed discussions of therapeutic choice, techniques and outcome. Cases previously presented at the surgeons net discussions and protocol cases will have priority. 7

Imaging working group Date: November 29, 2010, 13.00 19.00 November 30, 2010, 08.30 11.00 Chairman: Meeting room: Vesterbros torv M. Skorpil, Stockholm Musculoskeletal tumors: Imaging and referral guidelines for suspected sarcomas are going to be displayed on SSG homepage. Discussion and decision: - MRI protocol. - Referral guidelines. Lipomatous tumors. - Extra information on the homepage for special conditions, i.e. myxoid tumors, myositis ossificans, osteoid osteoma, follow-up post-operative MRI. - Staging with imaging. - Addresses to Sarcoma Imaging Centra for radiological consultation when benign tumors are suspected. Early response assessment for sarcomas Other questions 8

Oncology working group Date: November 29, 2010, 13.00 19.00 November 30, 2010, 08.30 11.00 Chairmen: Meeting room: Plenum S. Smeland, K. Sundby Hall, Oslo, L. Hjorth, Lund SSG experience in the treatment of osteosarcoma -EURAMOS II SSG planning of the next osteosarcoma protocol -EURAMOS I -EUROBOSS I -EUROLES S. Smeland, Oslo Treatment of Ewing s family tumors in SSG. Experiences since closure of ISGSSG III and IV K. Sundby Hall, Oslo, L. Hjorth, Lund SSG XX: Questions and technical aspects K. Sundby Hall, Oslo The SSG radiotherapy forum: presentation of difficult cases Ø. Bruland, Oslo, O. Monge, Bergen, J. Engellau, Lund Interferon in the treatment of fibromatosis: status of a new protocol by SSG J.P. Poulsen, Oslo, J. Engellau, Lund Histology driven chemotherapy in soft tissue sarcoma M. Eriksson, Lund Pazopanib in advanced GIST refractory to imatinib and sunitinib: A phase II Multicenter Study by the Scandinavian Sarcoma Group ( PAGIST ) M. Eriksson, Lund Long term morbidity after sarcoma treatment: SSG guidelines for follow-up. Report from the SSG working-group: L.H. Aksnes, Oslo, K. Engström, Gothenburg Studies outside of SSG: what is going on at the various SSG centres? All participants 9

Nurses and Physiotherapists working group Date: November 29, 2010, 13.00 19.00 November 30, 2010, 08.30 11.00 Chairman: Meeting room: Tivoli C. Våde, Oslo Status: Norge Sverige Danmark Ekonomi L. Smedberg, Stockholm SSG:s årsmøte i Malmö 2011 L. Våde, Oslo Monitorering av studier A-L. Salbu, Bergen Rapport från Den store kule dagen S. Granlien, Oslo Hejmdal, et nyt kræftrådgivningssted i Århus B. Hedegård, Århus Lymfedrenasje C. Buck, Bergen Fysioterapi i palliasjonsfasen for sarkompasienter H. Blegen, Oslo 10

Visceral and retroperitoneal sarcoma working group Date: November 30, 2010, 14.00 17.00 Chairmen: Meeting room: Plenum J. Åhlén, Stockholm, A. Bergenfelz, Lund Neoadjuvant treatment experiences from Gothenburg B. Nilsson, Gothenburg (15 min) Protocol: Neoadjuvant radiotherapy in retroperitoneal sarcoma O. Monge, Bergen (15 min) EORTC Randomized trial in retroperitoneal sarcoma: status of the protocol Ø. Bruland, Oslo, S. Stoldt, Oslo (15 min) Discussion of the protocols - How to proceed by SSG. (20 min) Protocol SSG XVIII/AIO: A randomized phase III study: final results to be presented? M. Eriksson, Lund (15 min) Pazopanib in advanced GIST refractory to imatinib and sunitinib: A phase II Multicenter Study by the Scandinavian Sarcoma Group ( PAGIST ) M. Eriksson, Lund (15 min) The SSG register for visceral and retroperitoneal sarcoma: status of INCA and future plans J. Åhlén, Stockholm (15 min) Report from GIST-GOALS 2010 M. Eriksson, Lund, K. Sundby Hall, Oslo (15 min) 11